Sort
15,842 grants matching “pancreatic cancer”
Research Program: Gastrointestinal Cancer
$118,761William M Grady · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
$118,737Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2022 · CA
Beta Imaging Probe Incorporated Needle for Biopsy of cancer
$118,700Farhad Daghighian · Intra Medical Imaging, Llc · R43 · FY2008 · CA
PEPTIDES AND PANCREATIC CANCER
$118,607Pennsylvania State Univ Hershey Med Ctr · K24 · FY2002 · CA
PEPTIDES AND PANCREATIC CANER
$118,607Pennsylvania State Univ Hershey Med Ctr · K24 · FY2000 · CA
Understanding metabolic heterogeneity in pancreatic cancer
$118,607Allison N Lau · Massachusetts Institute Of Technology · K99 · FY2018 · CA
PEPTIDES AND PANCREATIC CANER
$118,607Pennsylvania State Univ Hershey Med Ctr · K24 · FY2001 · CA
PEPTIDES AND PANCREATIC CANCER
$118,607Pennsylvania State Univ Hershey Med Ctr · K24 · FY2003 · CA
Understanding metabolic heterogeneity in pancreatic cancer
$118,607Allison N Lau · Massachusetts Institute Of Technology · K99 · FY2019 · CA
CELL CULTURE CORE
$118,558Erle S Robertson · University Of Pennsylvania · P30 · FY2013 · DK
Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
$118,479Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2009 · CA
Developmental Research Program
$118,454Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · P50 · FY2017 · CA
Keystone Symposia on Cellular and Molecular Basis of Metabolic Disorders Series
$118,450Andrew D Robertson · Keystone Symposia · R13 · FY2010 · DK
Tissue Banks
$118,439Christine A Iacobuzio-Donahue · Johns Hopkins University · P50 · FY2015 · CA
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$118,350Amato J. Giaccia · Stanford University · P01 · FY2012 · CA
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
$118,350Amato J. Giaccia · Stanford University · P01 · FY2012 · CA
Administrative Core
$118,290Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2022 · CA
Bayesian hierarchical nonlinear models for pharmacogenomic cytotoxicity studies
$118,275Brooke L Fridley · Mayo Clinic Rochester · R21 · FY2011 · GM
Digestive Diseases Training Program
$118,230David C Whitcomb · University Of Pittsburgh At Pittsburgh · T32 · FY2013 · DK
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$118,163Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Role of the MUC1/HIF-1a Complex in the kidney proximal tubule during ischemia-reperfusion injury.
$118,158Mohammad Al-Bataineh · University Of Pittsburgh At Pittsburgh · R03 · FY2022 · DK
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$118,067David C Linehan · University Of Rochester · R01 · FY2020 · CA
G-Protein Signaling in Pancreatic Cancer
$118,057Danny N. Dhanasekaran · Temple Univ Of The Commonwealth · R21 · FY2008 · CA
Elucidating the role of hepatic ketogenesis in pancreatic cancer cachexia and recovery
$118,041Paige C Arneson-Wissink · Oregon Health & Science University · K99 · FY2025 · CA
Elucidating the role of hepatic ketogenesis in pancreatic cancer cachexia and recovery
$118,041Paige C Arneson-Wissink · Oregon Health & Science University · K99 · FY2024 · CA